Volume 6 Supplement 4
Predictors of long term outcomes of IgA nephropathy
© Kabir et al; licensee BioMed Central Ltd. 2012
Published: 9 July 2012
IgA Nephropathy (IgAN) was first described by Berger and Hinglais in 1968. The correlations between clinical as well as histopathological features on presentation and disease progression still remain unclear.
To identify the key predictors of long term renal outcomes in IgAN.
Two hundred patients with biopsy proven IgAN were selected and their clinical as well as histopathological data was analysed for progression to End-stage renal disease (ESRD).
98 patients were used as the selected cohort. 21.5% of patients developed ESRD within 5 years and 28.8% within 10 years. Univariate studies showed that interstitial fibrosis, glomerulosclerosis, presence of fibrocellular crescents, proteinuria (g/24hrs) and raised serum creatinine levels at the time of biopsy were significant. (P value of <0.001 and 95% CI considered significant.) In the multifactorial analysis interstitial fibrosis and raised serum creatinine, lost their significance. (P value of <0.05 and 95% CI considered significant.)
Combination of proteinuria, glomerulosclerosis and fibrocellular crescents may contribute to poor renal outcomes in patients with IgAN. Interstitial fibrosis and raised serum creatinine levels may have solitary effects on disease progression as well.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.